Merck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted priority review for its request ...

Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Priority Cycles' Current Plus e-commuter bike delivers good range and power, plus features a low-maintenance Gates belt-drive ...

While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers ...

The Commissioner's National Priority Voucher (CNPV) programme will be available to companies aligned with pressing matters such as addressing a national health crisis, delivering more innovative cures ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

The US Food and Drug Administration (FDA) has granted priority review to AstraZeneca's supplemental biologics licence application (sBLA) for Imfinzi (durvalumab), a human monoclonal antibody, for ...

Priority E-Coast review: The competition. Priced at $1,999, the Priority E-Coast costs the same as our favorite ebike overall, Rad Power RadCity 5 Plus.